Results 71 to 80 of about 196,069 (283)
Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache
Neuropsychiatric Disease and Treatment, 2007 Stefan EversDepartment of Neurology, University of Münster, Münster, GermanyAbstract: Botulinum toxin A is increasingly used in the treatment of idiopathic and symptomatic headache disorders.
Stefan Evers
doaj
Case report of hypnic headache: a rare headache disorder with nocturnal symptoms
BMC Research Notes, 2017 Background Headache is one of the commonest complaints reported to physicians worldwide. Yet, arriving at the proper diagnosis can be a challenge in many patients. Although most headaches belong to common categories of migraine and tension-type headache,
Kanishka P. Dissanayake +2 more
doaj +1 more source
Arthritis Care &Research, EarlyView.Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel +6 more
wiley +1 more source
Drug abuse in patients with chronic headache
Медицинский совет, 2013 Person complaining of headache (HA) is a frequent patient of general practitioner. Among those at least 10% are patients with chronic HA and cephalgia occuring more frequently than 15 days per month for at least 3 months [4, 10].
V. V. Osipova, V. V. Golubeva
doaj +1 more source
Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria [PDF]
, 2018 Idiopathic intracranial hypertension (IIH) is characterized by intracranial pressure >28 cmH2O in the absence of identifiable causes. Aim of this paper is to describe the clinical phenotype of pediatric IIH and to analyze the applicability of ICHD-3 ...
Barbara Battan +8 more
core +2 more sources
Arthritis Care &Research, Accepted Article.Objective Studies of damage accrual in patients with systemic lupus erythematosus (SLE) show associations with disease activity measured by the SLE Disease Activity Index 2000 (SLEDAI‐2K), but these associations are imperfect. SLEDAI scores are powerfully influenced by weightings (1‐8) assigned to each domain.
Kevin Zhang +8 more
wiley +1 more source
Treatment for chronic daily headache by using auxiliary and alternative methods
Неврология, нейропсихиатрия, психосоматика, 2015 Chronic daily headache (CDH) is one of the top 10 causes of adult disability and one of the 5 most common causes of female disability. To treat patients with CDH is one of the most difficult tasks in neurological practice.
V. A. Golovacheva +2 more
doaj +1 more source
Acute treatment of migraine: quo vadis? [PDF]
, 2017 Migraine represents the third cause of disability in the worldwide population aged under 50 years. Facing this enormous social impact, only onabotulinumtoxinA has been evaluated, on serendipity basis, as effective chronic migraine preventative ...
Martelletti, Paolo
core +1 more source
Laser‐Assisted Processing and Modification of Bioactive Glasses: A Review
Advanced Healthcare Materials, EarlyView.Laser technologies provide powerful tools to process and transform bioactive glasses for advanced biomedical applications. This review discusses laser‐matter interaction mechanisms, laser surface engineering, and laser‐assisted fabrication of scaffolds and nanofibers.
Antonio Riveiro +8 more
wiley +1 more source
Validation of a guideline-based decision support system for the diagnosis of primary headache disorders based on ICHD-3 beta [PDF]
, 2014 BACKGROUND: China may have the largest population of headache sufferers and therefore the most serious burden of disease worldwide. However, the rate of diagnosis for headache disorders is extremely low, possibly due to the relative complexity of ...
Mianwang He +5 more
core +1 more source